Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report)’s stock price reached a new 52-week high on Thursday . The stock traded as high as $365.08 and last traded at $365.08, with a volume of 92 shares trading hands. The stock had previously closed at $309.37.
Bio-Rad Laboratories Stock Performance
The firm’s 50 day moving average is $311.90 and its 200-day moving average is $290.30. The stock has a market capitalization of $9.76 billion, a price-to-earnings ratio of 44.25 and a beta of 0.93. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.33 and a current ratio of 3.14.
About Bio-Rad Laboratories
Bio-Rad Laboratories, Inc is a global provider of innovative products and systems that serve the life science research and clinical diagnostics markets. The company operates through two primary segments: Life Science, which delivers instruments, consumables and software for research applications, and Clinical Diagnostics, which offers quality control materials and reagent systems for blood typing, immunology and molecular testing. Bio-Rad’s product portfolio supports a wide range of applications, including protein analysis, gene expression, cell biology and digital PCR.
In the Life Science segment, Bio-Rad develops and markets technologies such as electrophoresis and imaging systems, chromatography instruments, laboratory consumables and software platforms that streamline experimental workflows.
Featured Articles
- Five stocks we like better than Bio-Rad Laboratories
- Sociedad Química y Minera’s Lithium Boom Is Back, But Iodine Steals the Show
- Forget Chips: These 3 Stocks Are Building the AI Data Center Boom
- AIxCrypto Dumps Its Crypto and Goes All In on Robotics
- AST SpaceMobile’s FCC Test Arrives as Investors Weigh a Costly Q2 Miss
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
